Abiopharma

The Company, through different subsidiaries, has the capacity to produce 21 different NMPA-approved medicines, 14 NMPA-approved health supplement products and 10 hemp derivative products. In addition, the Company, through its wholly owned subsidiaries, holds one patent for utility models, five patents for external design, and three trademarks in China. The Company is licensed to sell its products, including its medical drugs, only in the PRC. The Company has newly developed certain products that are derived from hemp. It began to sell its new products since May 2018. Hemp Oil, Hemp Protein Powder, Hemp Polypeptide and Collagen Peptide are sold through Humankind. Other cosmetics are sold through HLJ Huimeijia.

Additional info from OTC:
The Company, through different subsidiaries, has the capacity to produce 21 different NMPA-approved medicines, 14 NMPA-approved health supplement products and 10 hemp derivative products. In addition, the Company, through its wholly owned subsidiaries, holds one patent for utility models, five patents for external design, and three trademarks in China. The Company is licensed to sell its products, including its medical drugs, only in the PRC. The Company has newly developed certain products that are derived from hemp. It began to sell its new products since May 2018. Hemp Oil, Hemp Protein Powder, Hemp Polypeptide and Collagen Peptide are sold through Humankind. Other cosmetics are sold through HLJ Huimeijia.